Literature DB >> 9708688

Immunohistochemical and serological comparison of idiopathic and hepatitis C virus-associated forms of oral lichen planus.

A C Kirby1, G L Lodi, I Olsen, S R Porter.   

Abstract

The oral form of the inflammatory disease lichen planus occurs spontaneously due to unknown aetiological factors. However, it has recently been observed to occur with increased frequency in patients infected with the hepatitis C virus. Because of the prominent role of adhesion molecules in immune cell interactions, we have compared the expression of these antigens in the hepatitis C virus-associated and idiopathic forms of the disease. The results show similar patterns of expression of very late activation antigen-4, lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1, but relatively elevated levels of these antigens in oral lichen planus patients with no hepatitis C virus infection. In addition to differences in Langerhans cell distribution, serum levels of "soluble" intercellular adhesion molecule-1 as well as immunoglobulin G were significantly increased in the hepatitis C virus-associated group. These findings show that there are some differences in the lesional and systemic immune reactivities of the two types of oral lichen planus which may be related to possibly distinct pathogenic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708688     DOI: 10.1046/j.0909-8836.1998.eos106404.x

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  2 in total

1.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

2.  Periodontopathogen profile of healthy and oral lichen planus patients with gingivitis or periodontitis.

Authors:  Abdullah Seckin Ertugrul; Ugur Arslan; Recep Dursun; Sema Sezgin Hakki
Journal:  Int J Oral Sci       Date:  2013-06-07       Impact factor: 6.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.